{"url_path":"/sec/shc/8-k/2026-05-13/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/1822479/0001193125-26-221630-index.html","accession_number":"0001193125-26-221630","cik":"0001822479","ticker":"SHC","issuer_name":"Sotera Health Co","edgar_url":"https://www.sec.gov/Archives/edgar/data/1822479/0001193125-26-221630-index.html","primary_entity_key":"0001822479","primary_entity_name":"Sotera Health Co"},"word_count":146,"has_tables":true,"body_markdown":"Item 9.01\n\nFinancial Statements and Exhibits.\n\n(d) Exhibits\n\n \n\nExhibit\nNumber\n\n  \n\nDescription\n\n 1.1\n  \n[Underwriting Agreement, dated May 11, 2026, among the Company, Goldman Sachs & Co. LLC, as underwriter, and the selling stockholders named in Schedule 2 thereto.](d113042dex11.htm)\n\n 5.1\n  \n[Opinion of Cleary Gottlieb Steen & Hamilton LLP.](d113042dex51.htm)\n\n10.1\n  \n[Stockholders Agreement (filed as Exhibit 10.9 to the Company’s Annual Report for the year ended December 31, 2020)](http://www.sec.gov/Archives/edgar/data/1822479/000182247921000018/shc_20201231xexhibitx10x9.htm)\n\n23.1\n  \n[Consent of Cleary Gottlieb Steen & Hamilton LLP (included as part of Exhibit 5.1).](d113042dex51.htm)\n\n104\n  \nCover Page Interactive Data File (embedded within the Inline XBRL document).\n\n \n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\n \nSotera Health Company\n\n \n\n \n (Registrant)\n\nDate: May 13, 2026\n \n\n \nBy:\n \n\n/s/ Jonathan M. Lyons\n\n \n\n \n\n \nJonathan M. Lyons\n\n \n\n \n\n \nSenior Vice President and Chief Financial Officer"}